Elevated PARP activity is observed in the motor neurons of the ALS spinal cord, and inhibition of PARP mitigates hnRNP A1- or TDP43-mediated neurotoxicity in cell and drosophila models of ALS22,24. The gene discussed is PARP1; the disease is amyotrophic lateral sclerosis type 22.